1,4‐Dihydropyridine Ca²⁺channel antagonists and activators: A comparison of binding characteristics with pharmacology

This publication has 87 references indexed in Scilit:

• Are dihydropyridine binding sites voltage sensitive calcium channels?
  Life Sciences, 1984
• Radioreceptor and High‐Performance Liquid Chromatographic Assays for the Calcium Channel Antagonist Nitrendipine in Serum
  The Journal of Clinical Pharmacology, 1983
• Nifedipine in the Treatment of Migraine in Patients with Raynaud's Phenomenon
  New England Journal of Medicine, 1983
• [3H]Nimodipine specific binding to cardiac myocytes and subcellular fractions
  Biochemical and Biophysical Research Communications, 1983
• Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's Phenomenon
  New England Journal of Medicine, 1983
• A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: Evidence for a calcium channel
  Life Sciences, 1983
• Specific calcium antagonist binding sites in brain
  Life Sciences, 1982
• Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem
  Biochemical and Biophysical Research Communications, 1982
• The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats
  Life Sciences, 1982
• High affinity binding of a calcium channel antagonist to smooth and cardiac muscle
  Biochemical and Biophysical Research Communications, 1982